Search results for "cancer diagnosis"

Main features At least one-month room temperature stability Improved sensitivity of proprietary RdRP and E assays  Multiplexed version  With RNase P assay as an internal control SARS-CoV-2 full genomic RNA spiked with human RNA used as a positive control 100% clinical accuracy Ultrasensitive limit of detection of 2 RNA copies/rxn for all targets (SARS-CoV-2, IAV and IBV) 100% specific for SARS-CoV-2, and WH…

Quantitative in-vitro FIA rapid diagnostic POCT analyzer

Bio-Rad leads investment to support the launch of ColoSense® to advance diagnostic innovations for inflammatory bowel disease

One test that can expedite NSCLC treatment selection decisions. The Oncomine Dx Target Test is the first targeted NGS-based in vitro diagnostic test for NSCLC, simultaneously delivering multiple biomarker results from one sample within four days and helping inform treatment decisions.

Explore our exclusive interviews and free resources to help support your cancer research, diagnostics, and therapy development

Agilents High-Resolution C Scanner provides the advanced capabilities your laboratory needs to perform high-density microarray analysis. Optimized through SureScan High Resolution Technology, the dynamic range is now 20X greater than other leading scanners. Seamless data processing and the industrys first dynamic autofocus helps deliver the clarity and quality your research requires. Superior resolution, (10 microns down to 2…

Source BioScience have over 15 years of sequencing experience and a unique network of state of the art sequencing laboratories meaning we are perfectly placed to be your local provider for sequencing. Source BioScience have a reputation for providing the highest quality data combined with excellent turnaround times. Pre-paid sequencing vouchers are available for purchase which offer both cost and time savings.

Eton provides the following sequencing services tailored to your specific research.

Erasmus University Medical Center uses ENPICOM’s IGX Platform and services to advance their research on identifying cancer nanobodies

Uniquely shaped red blood cells observed for the first time in patient blood could be breakthrough in diagnosis of myelodysplastic syndrome (MDS)

Explore the benefits of a combined methylation-sensitive restriction enzyme and ddPCR approach to detect DNA methylation in healthy and disease states.

Cytovale’s IntelliSep sepsis test highlights a new model for ED triage that’s already delivering systemwide clinical and economic value

Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows

Clinical mass spectrometry testing offers sensitivity and specificity, providing clinicians with additional diagnostic insights

Activities highlight comprehensive diagnostics solutions to help effectively assess clinical risk and diagnose disease, advance precision medicine and further clinical research

Transforming cancer diagnostics and precision medicine through novel liquid biopsy mRNA technology.